BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Escuela de doctorado
University of Alberta
Edmonton, CanadáPublicaciones en colaboración con investigadores/as de University of Alberta (19)
2023
-
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Journal of Pathology: Clinical Research, Vol. 9, Núm. 3, pp. 208-222
2021
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
2019
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973
2017
-
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
American Heart Journal, Vol. 193, pp. 46-54
2016
-
Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis
Transplant International, Vol. 29, Núm. 11, pp. 1216-1225
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
2015
-
Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis
Heart, Vol. 101, Núm. 19, pp. 1554-1561
-
Disability in bipolar i disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0
Journal of Affective Disorders, Vol. 174, pp. 353-360
-
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: A patient-level analysis of the randomized early routine invasive clinical trials
JACC: Cardiovascular Interventions, Vol. 8, Núm. 1, pp. 166-174
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477
-
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3
2013
2011
-
Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP)
Schizophrenia Research, Vol. 130, Núm. 1-3, pp. 137-142
2010
-
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: A meta-analysis
European Heart Journal, Vol. 31, Núm. 17, pp. 2156-2169
-
Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)
Schizophrenia Research, Vol. 116, Núm. 2-3, pp. 243-251
2009
-
Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder
Health and Quality of Life Outcomes, Vol. 7
2008
-
Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia
Schizophrenia Research, Vol. 99, Núm. 1-3, pp. 139-148
2004
-
Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report
Cancer Research